Trial intelligence / Profile preview

Pulmozyme in 3- to 5-Year-Old Patients With Cystic Fibrosis

NCT00680316Phase 4Terminated

Sponsor
Genentech
Start
Jun 2008
Primary completion
May 2009
Modality
Replacement Enzymes
01

Overview

A Phase 4 trial of deoxyribonuclease I in cystic fibrosis (CF), sponsored by Genentech. Started Jun 2008; status: terminated.

02

Drugs

deoxyribonuclease I
03

Conditions

cystic fibrosis (CF)

Beyond the preview

Go deeper on NCT00680316.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00680316.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call